Lumida
/FENC
⌘K
Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc

FENC
$10.96USD↓-3.01%-0.34 today

MARKET CAP

384.3M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$11 – $12

52W RANGE

$6
$13

AI Summary

Stalk
StalkMedium

FENC remains in a high-confidence Stage 2 advancing uptrend with an active momentum breakout confirming medium-term bullish structure, but price is currently extended above rising EMAs with overbought RSI and options score, making short-term execution unfavorable; deferred entries on a healthy pullback into support are advised.

  • ↑Q2 revenue rose 78% YoY to $17.1 M with net income of $1.97 M
  • ↑Non-GAAP EBITDA turned positive at $2.8 M vs a $1.2 M loss prior year
  • ↓Negative earnings yield and low book-to-price suggest overvaluation
Full analysis →
Insider Trades26 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Mar 26, 2026BuyFENCChristiana Marie CioffiChief Strategy Officer4,700$4.23$384.3M-17.28%+93.98%$19.9K+3.23%—Stalk
Mar 26, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER13,072$5.10$384.3M-17.28%+93.98%$66.7K+1.25%—Stalk
Feb 18, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER2,450$4.08$384.3M-17.28%+93.98%$10.0K+0.24%—Stalk
Jan 23, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER10,000$2.45$384.3M-17.28%+93.98%$24.5K+0.98%—Stalk
Jan 15, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER10,000$2.45$384.3M-17.28%+93.98%$24.5K+0.98%—Stalk
Jan 7, 2026BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER14,184$2.45$384.3M-17.28%+93.98%$34.8K+1.40%—Stalk
May 22, 2025BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER8,220$5.10$384.3M-17.28%+93.98%$41.9K+0.82%—Stalk
May 16, 2025BuyFENCJeffrey S. HackmanChief Executive Officer15,000$6.97$384.3M-17.28%+93.98%$104.6K+1449.28%—Stalk
Nov 18, 2024BuyFENCRobert AndradeCHIEF FINANCIAL OFFICER15,816$2.45$384.3M-17.28%+93.98%$38.7K+1.98%—Stalk
Aug 1, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.25$384.3M-17.28%+93.98%$15.2K-1.28%—Stalk
Jul 2, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.13$384.3M-17.28%+93.98%$14.9K-1.28%—Stalk
Jun 3, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$6.76$384.3M-17.28%+93.98%$16.4K-1.28%—Stalk
May 1, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER2,431$9.11$384.3M-17.28%+93.98%$22.2K-1.28%—Stalk
Apr 19, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,890$5.82$384.3M-17.28%+93.98%$517.1K+0.00%—Stalk
Apr 17, 2024BuyFENCAdrian HaighCHIEF OPERATING OFFICER44,444$2.31$384.3M-17.28%+93.98%$102.7K+200.00%—Stalk
Apr 17, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,888$6.04$384.3M-17.28%+93.98%$536.7K-8.43%—Stalk
Apr 15, 2024BuyFENCAdrian HaighCHIEF OPERATING OFFICER44,444$2.31$384.3M-17.28%+93.98%$102.7K+200.00%—Stalk
Apr 15, 2024SellFENCAdrian HaighCHIEF OPERATING OFFICER88,888$6.30$384.3M-17.28%+93.98%$559.8K-8.09%—Stalk
Apr 4, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER88,583$10.82$384.3M-17.28%+93.98%$958.7K-11.51%—Stalk
Apr 3, 2024SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER40,584$10.78$384.3M-17.28%+93.98%$437.5K-6.56%—Stalk
Mar 26, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER13,975$10.90$384.3M-17.28%+93.98%$152.3K-13.22%—Stalk
Mar 25, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER13,975$11.00$384.3M-17.28%+93.98%$153.7K-11.67%—Stalk
Jan 4, 2024SellFENCRobert AndradeCHIEF FINANCIAL OFFICER30,000$10.53$384.3M-17.28%+93.98%$315.8K-10.55%—Stalk
Dec 28, 2023BuyFENCRosty RaykovCHIEF EXECUTIVE OFFICER12,196$4.58$384.3M-17.28%+93.98%$55.8K+0.58%—Stalk
Nov 8, 2023SellFENCRosty RaykovCHIEF EXECUTIVE OFFICER25,044$7.76$384.3M-17.28%+93.98%$194.3K-4.19%—Stalk
Nov 3, 2023BuyFENCRosty RaykovCHIEF EXECUTIVE OFFICER74,793$1.59$384.3M-17.28%+93.98%$118.9K+4.09%—Stalk